This study was designed to investigate whether ANRIL affected the aetiology of coronary artery disease (CAD) by acting on downstream miR-181b and NF-κB signalling.
studies mentioning the pathogenesis of atherosclerosis and development of ischaemic heart disease, around 30% of CAD cases failed to be explained by known cardiovascular hazards. 3, 4 It was before manifested that CAD could be taken as a consequence of progressive inflammation, 5 yet the exact mechanisms underlying dysfunctions of CAD remained vague.
Long non-coding RNAs (lnc RNAs), a type of transcripts comprising >200 nucleotides, were involved in the aetiology of diverse human disorders through epigenetic, transcriptional and post-transcriptional regulations. 6, 7 Interestingly, it was appeared that lncRNAs also participated in the development of cardiovascular diseases, including heart failure, cardiac hypertrophy, cardiac metabolic diseases and myocardial infarction. 8 Among them, lncRNA ANRIL, also named as CDKN2BAS, was ranked as the best replicating genetic risk factor for CAD, 8 and it was speculated to alter expressions of related proteins through RNA interference, gene silencing, chromatin remodelling and DNA methylation. 9 In addition, the function of lncRNAs was often mediated through the regulation of microRNAs (miRNAs), which post-transcriptionally regulate gene expression by binding to the 3′ untranslated region (UTR) of mRNAs. 10 For instance, it was documented that ANRIL modifying miR-181b could boost a series of vicious transformations that were relevant to human vascular inflammation. 11 However, whether ANRIL would impact on miR181b to regulate the onset or progression of CAD remained unanswered.
The miR-181 pointed out here has been revealed to affect different aspects of cell life activities, including cell proliferation, cell differentiation and cell death. 12, 13 Furthermore, miR-181b was discovered to inhibit NF-κB-mediated endothelial cell activation by lowering the expression of importin-α3 (IPOA3), a key protein assisting in translocation of NF-κB from cytoplasm to nucleus. 14 Notwithstanding, the role of miRNA-181b in chronic inflammatory disease, such as atherosclerosis, has not been examined. However, in the vascular endothelium, NF-κB activation induces the expression of pro-inflammatory genes, which seemed as a pivotal parameter for the occurrence and development of atherosclerosis. [15] [16] [17] All in all, it was hypothesized that ANRIL, miR-181b and NF-κB might function to modify the aetiology of atherosclerosis. In response, this study was designed to investigate whether ANRIL regulated the presence and progression of CAD by acting on downstream miR-181band NF-κB signalling.
| MATERIALS AND METHODS

| Inclusion of subjects
Altogether 327 CAD patients diagnosed by angiography were 
| Establishment of mice models and sample collection
The SD rats of clean grade (male; 7-week; 220-250 g) were provided by the experimental animal centre of the 455th Hospital of Chinese People's Liberation Army. The rats were anaesthetized with usage of 50 mg/kg pentobarbital sodium. Their four limbs were subcutaneously inserted with needle electrodes, and changes of electrocardiogram were monitored. After tracheal intubation, the rats' breath was controlled at 90 times/min, and tidal volume was set as 3-4 mL. The rats were disinfected and operated with thoracotomy before their pericardium was cut. After 30-minute successful ligation, the artery clamp was loosen, and reperfusion was sustained for 90 minutes to cause ischaemia reperfusion injury.
About 10 minutes later, ligation was considered as successful if STsegment elevation was observed within electrocardiogram, and those without ST-segment elevation was sifted out. The cardiac tissues of rats were taken out, and the ischaemic myocardium within left ventricle of the heart was clipped and was frozen within liquid nitrogen at −80°C.
| Determination of cardiac function
Sacculus was inserted through atrioventricular valve, and pressure transducer was connected with the computer. Then left ventricular systolic pressure (LVSP), maximum change rate of left intraventricular pressure (±dp/dtmax) and coronary blood-flow volume (CF) were recorded. 
| Cell culture
| Cell transfection
The shRNA (shRNA-ANRIL) targeting ANRIL, the shRNA lentivirus particles added with interfering nucleotides (shRNA-NC), pcDNA3. 
| Colony formation assay
The transfected cells were seeded at 1 × 104 within culture dishes of a 35-mm diameter. The cells stained with trypan blue were observed and counted in triplicate within 6 weeks. Then cells were dissociated and were suspended in the medium containing 0.3%
agar. The colonies exceeding 0.5 mm in diameter were counted after 14 days.
| Cell proliferation assay
All the procedures were carried through in line with the instructions of CCK-8 kit (Dojindo Laboratories, Kumamoto, Japan). After 72-hour transfection, 2 × 10 4 cells (100 μL) were inoculated within each well of 96-well culture plate. About 3-4 hours later when cells grew against the wall, 100 μL RPMI 1640 complete medium and 10 μL CCK-8 were added. Then, the cells were cultured in 5% CO 2 at 37°C for 2 hours.
The D450 values would be determined with a microplate reader (infinite M200, Tecan, Austria) at the wavelength of 450 nm.
| Cell apoptosis assay
When cells were re-suspended within 500 μL binding buffer, 5 μL 
| Western blotting
We prepared RIPA lysis buffer to extract proteins from tissues and cells, and Bradford method was employed to measure the protein concentration. Subsequently, equal amounts (ie, 30 μg) of proteins were electrophoresed on the 6% or 10% polyacrylamide gel, and the isolated proteins were then transferred onto the polyvinylidene Gene Genius gel imaging system (Syngene, Cambridge, UK).
| Dual luciferase reporter gene assay
The ANRIL fragments that covered specific miR-181b binding sites were cloned into the pmirGLO dual luciferase expression vector 
| Statistical analyses
All the statistical analyses were performed with the aid of GraphPad
Prism software (GraphPad Prism Software Inc., San Diego, USA). Student's t test or one-way ANOVA test was employed to compare quantitative data (mean ± SD), and chi-square test was applied for evaluation of enumeration data. A P value < 0.05 was considered as a mark of significant differences.
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The Expressions of lncRNA ANRIL and miR-181b were Compared between Coronary Artery Disease (CAD) Tissues/Cells and Normal Tissues/Cells. A, ANRIL and miR-181b expressions were compared between CAD tissues and normal tissues. *P < 0.05 when compared to normal tissues. B, ANRIL and miR-181b expressions were compared between HUVECs and HCAECs. *P < 0.05 when compared to HUVECs. C, The survival rates of CAD patients with differentially expressed ANRIL and miR-181b were compared. D, ANRIL expressions were negatively correlated with miR-181b expressions within CAD tissues 3 | RESULTS
| Association of ANRIL and miR-181b expressions with baseline characteristics of CAD patients
Founded on the percentage of coronary artery stenosis, the CAD patients were categorized into LAD1 group (81%-100%, severe), LAD2 group (51%-80%, moderate), LAD 3 group (30%-50%, mild) and healthy group. According to Figure 1A , up-regulated ANRIL expression and down-regulated miR-181b expression were observed within CAD patients when compared to the healthy group (P < 0.05). It was further revealed that ANRIL expression increased with the rising degree of LAD (P < 0.05), yet miR-181b expression followed a tendency opposite to ANRIL (P < 0.05). Similar to the results of tissues, ANRIL was expressed more within HCAECs than within HUVECs, and miR-181b expression within HCAECs appeared lower than within HUVECs (P < 0.05)( Figure 1B ). More than that, both highly expressed ANRIL and lowly expressed miR-181b were associated with CAD population aged over 60 years old, with smoking history, with symptoms of hypertension and hyperlipidemia, with Figure 1C ). At the same time, Spearman's correlation analysis unfolded that miR-181b expressions were negatively correlated with ANRIL expressions among the CAD patients investigated (rs = −0.534, P < 0.001) ( Figure 1D ).
| Variation of cardiac functions within CAD mice models
When compared to NC group and sham-operated group, the CAD mice models were observed with remarkably decreased LVSP, +dp/dtmax and -dp/dtmax (all P < 0.05). Following an analogous trend, CAD mice models exhibited a significantly inhibited CF in comparison with NC group and sham-operated group (P < 0.05) (Figure 2A ). However, there was no significant distinction of LVSP, +dp/dtmax, -dp/dtmax NC and CF within NC group from those within sham-operated group (P > 0.05). 
| ANRIL targeted miR-181b to inhibit its expression
The luciferase activity of the pmirGLO-ANRIL-Wt+miR-181b group seemed quite lower than that of pmirGLO-ANRIL-Mut+miR-181b group (P < 0.05), and scarcely any differences were viewed between pmirGLO-ANRIL-Mut+miR-181b group and pmirGLO+NC group (P > 0.05) ( Figure 6A ). In addition, qRT-PCR results delivered a message that highly expressed ANRIL also notably brought down miR181b expression and raised p50/p65 expressions within HCAECs 
| MiR-181b prohibited HCAECs' survival, viability and apoptosis, along with EMT-specific proteins within HCAECs via targeting NF-κB
The miR-181b mimic transfected with pmirGLO-NF-κB-Wt displayed a luciferase activity smaller than miR-181b mimic+pmirGLO-NF-κB-Mut group (P < 0.05), whose luciferase activity was approximate to that of miR-NC+pmirGLO group without statistical significance (P > 0.05) ( Figure 6D ). Meanwhile, we found that up-regulation or down-regulation of miR-181b expression could accordingly alter NF-κB p50 and p65 expressions (P < 0.05) ( Figure 6E ).
The results of CCK8 assay and colony formation assay both showed that the viability and survival status of HCAECs were more vigorous within miR-NC+NF-κB activator group than within miR-NC group (P < 0.05), suggesting that NF-κB suppressed the miR- apoptosis. What's more, miR-NC+NF-κB activator group was determined with lowly expressed E-cadherin and highly expressed N-cadherin and vimentin, when compared to miR-NC group (P < 0.05).
| MiR-181b repressed HCAECs' capacity to release inflammatory factors and vascular-protective factors through modulation of NF-κB
MiR-NC+NF-κB activator group was found to secrete more inflammatory factors (ie, IL-6, IL-8, NF-κB, TNF-α, iNOS, ICAM-1, VCAM-1 and COX-2) and vascular-protective factors (ie, VEGF and HSP 70) than miR-NC group (P < 0.05) (Figure 8 ). And miR-NC group remained higher release of the above-mentioned inflammatory factors and vascular-protective factors than miR-181b mimic group (P < 0.05).
| DISCUSSION
Coronary artery disease, one principal cause for heart diseaseinduced death, has been on the rise in its prevalence because of increased populations with obesity and diabetes. [19] [20] [21] Currently, the treatments for CAD mainly incorporated chemotherapy, percutaneous coronary intervention, coronary artery bypass grafting and so 
The Effects of ANRIL and miR-181b on Viability and Survival of HUVECs and HCAECs were Evaluated. A, ANRIL expressions were determined after transfection of si-1#, si-2# or pcDNA-ANRIL. *P < 0.05 when compared to NC. B, MiR-181b expressions were determined after transfection of miR-181b mimic or miR-181b inhibitor. *P < 0.05 when compared to NC. C, The viability of HCAECs was compared among pcDNA-ANRIL, si-ANRIL, miR-181b mimic, miR-181b inhibitor and NC groups. *P < 0.05 when compared to NC. D, The survival rates of HCAECs were compared after transfection of pcDNA-ANRIL, si-ANRIL, miR-181b mimic, miR-181b inhibitor or NC. *P < 0.05 when compared to NC GUO ET AL. 
on, it still brought about high mortality. 22 One main reason was believed as that the inaccurate and incomplete diagnostic strategies for CAD resulted in a spike in the rate of missed diagnosis. Therefore, early detection of CAD was of great necessity, and it had high application value to develop bio-diagnostic markers featuring high sensitivity and convenience.
LncRNAs, a class of non-coding RNAs with a length greater than 200 nt, can be involved in genetic regulation transcriptionally and post-transcriptionally, and some of them, including Bvrt, Fendrr, ANRIL, MIAT, MyHeart (Mhrt), functioned essentially in the occurrence of heart diseases, including myocardial infarction, cardiomyopathy, heart failure and atherosclerosis. [23] [24] [25] [26] [27] [28] ANRIL was a 3.8-kblong non-coding RNA transcribed from chromosome 9p21, which was a crucial locus of genetic sensitivity for CAD. The Correlations among ANRIL, miR-181b and NF-kB within HCAECs were Verified. A, The luciferase activities were compared between miR-181b mimic+ANRIL wt and miR-181b mimic+ANRIL mut groups. *P < 0.05 when compared to miR-181b mimic+NC. B, MiR181b expressions were detected after transfection of pcDNA-ANRIL or si-ANRIL. *P < 0.05 when compared with NC. C, ANRIL expressions were detected after transfection of miR-181b mimic or miR-181b inhibitor. D, The luciferase activities were compared between miR-181b mimic+NF-kB wt and miR-181b mimic+NF-kB mut groups. *P < 0.05 when compared to miR-181b mimic+NC. E, NF-kB p50 and p65 expressions were detected after transfection of pcDNA-ANRIL, si-ANRIL, miR-181b mimic or miR-181b inhibitor. *P < 0.05 when compared to NC secreting inflammatory factors, and thereby triggering atherosclerosis. Zhou et al 34 firstly disclosed that ANRIL and related inflammatory factors were up-regulated within ECs under the stimulation of pathogens, which was mediated by up-regulated TNF-α that was caused by NF-κB signalling. Also ANRIL was capable of binding to PRC-associated protein (ie, Yin Yang 1) to induce or restrain genetic expressions (eg, IL6 and IL8) that were related with inflammatory responses. [35] [36] [37] Thus, it was quite acceptable that ANRIL could act on NF-κB signalling to induce inflammation, thereby generating CAD-specific cell activities (Figures 3-8 ).
LncRNAs usually modulated disease progression through functioning on coding or non-coding genes to boost or hinder the regulatory network within cellular processes. 38, 39 This investigation held that the regulatory role of ANRIL in CAD was played via regulation of miR-181b (Figures 3-6 ), which has been a focus among CAD studies. In particular, plasma miR-181b was under-expressed remarkably within CAD patients than within normal subjects. 14 Furthermore, it was mirrored that decreased miR-181b restrained vascular remodelling by activating TGF-β/pSmadD2/3 pathway, 40 and addition of angiotensin II into cardiac fibroblasts could significantly down-regulate miR-181b expression. 41 In addition, it has been illuminated that miR-181b might suppress breast cancer cells' capacity of metastasis by targeting CXCL1 and CXCL2, a couple of inflammatory cytokines. [42] [43] [44] He et al 45 With respect to inflammatory reactions, it was displayed that MiR-181b could target Importin-3(IPOA3) to restrain nuclear transfer of NF-κB, thereby down-regulating VCAM-1 expression and relieving inflammatory responses. 14 Moreover, after intravenous injection of miR-181b mimic into atherosclerosis mice, the convergence of macrophages, CD 4+ T cells and other inflammatory cells were held up, along with decreased expressions of inflammatory markers.
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Similar to this, our study verified that miR-181b could induce inflammatory reactions both in vivo and in vitro, which was specifically manifested as that the expressions of IL-6, IL-8, TNF-α, iNOS, ICAM-1, VCAM-1, COX-2 were down-regulated ( Figures 5 and 8 ).
The NF-κB signalling mentioned above not only resulted in incremental apoptosis and declined migration of cancer cells, 48 Lastly, curves were not fitted to assess if ANRIL and miR-181b could act as biomarkers for early-diagnosis of CAD.
ACKNOWLEDG EMENT
None. 
